|
Delayed
London S.E.
12:13:02 25/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.6100 GBX | +6.09% |
|
+6.09% | +16.19% |
| 11:19am | Thalia Therapeutics Completes Initial Synthesis for Cardiovascular siRNA Program | MT |
| 10:32am | Thalia Therapeutics Begins Preclinical Work on Proposed Cardiovascular Disease Therapy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 9.18M | - | - | - | - | - |
| 71.94B | |||||
| 59.35B | |||||
| 27.16B | |||||
| 26.54B | - | ||||
| 24.93B | - |
Select your edition
All financial news and data tailored to specific country editions
